Volastra
Tarun Kapoor is a leading chemical biology researcher who innovates in using chemistry-based approaches to decipher cellular mechanisms, focusing on cell division and cancer. His research has lead to first-in-class drug-like chemical inhibitors for several targets, including molecular motor proteins, cell cycle and cytoskeleton regulators and ribosome assembly factors. Together, these studies have catalyzed the development of new therapeutic approaches. In 2001 he began his career at The Rockefeller University as an Assistant Professor and Head of the Laboratory of Chemistry and Cell Biology. He was named Associate Professor in 2005 and in 2008 became the Pels Family Professor. In 2012 he also became the Associate Director of The Tri-Institutional Program in Chemical Biology. In 2016 he was appointed Director of the Pels Family Center for Biochemistry and Structural Biology and Head of the Selma and Lawrence Ruben Laboratory of Chemistry and Cell Biology
Dr. Kapoor is a member of the editorial boards of several scientific journals, review panels for research funding agencies, and advisory boards of biotechs and research institutes.
This person is not in the org chart
This person is not in any offices
Volastra
1 followers
Volastra Therapeutics, Inc., is developing novel therapies to treat and prevent the formation of metastatic disease. Launched from the laboratory of Dr. Lewis Cantley, along with Drs. Olivier Elemento and Samuel Bakhoum, Volastra has identified the mechanisms by which CIN drives the formation and proliferation of metastases. Following initial evidence that a patient’s CIN status is prognostic for metastasis and that CIN alters metastasis and overall survival in mouse models, the company is discovering mechanisms and pathways by which CIN modulates metastatic disease to develop novel therapeutics.